chr3-29434900-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001003793.3(RBMS3):c.233T>A(p.Ile78Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00062 in 1,613,558 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I78V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001003793.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RBMS3 | NM_001003793.3 | c.233T>A | p.Ile78Asn | missense_variant | 2/15 | ENST00000383767.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RBMS3 | ENST00000383767.7 | c.233T>A | p.Ile78Asn | missense_variant | 2/15 | 1 | NM_001003793.3 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000214 AC: 53AN: 247948Hom.: 0 AF XY: 0.000231 AC XY: 31AN XY: 134180
GnomAD4 exome AF: 0.000644 AC: 941AN: 1461320Hom.: 0 Cov.: 30 AF XY: 0.000619 AC XY: 450AN XY: 726930
GnomAD4 genome AF: 0.000388 AC: 59AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74426
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2022 | The c.233T>A (p.I78N) alteration is located in exon 2 (coding exon 2) of the RBMS3 gene. This alteration results from a T to A substitution at nucleotide position 233, causing the isoleucine (I) at amino acid position 78 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at